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        The innate immune system provides effi   cient 
protection from microbial infection of vulner-
able body surfaces through the expression of 
small cationic peptide antibiotics named anti-
microbial peptides. In the small intestine, they 
are produced in large quantities by Paneth cells 
situated at the lower end of intestinal crypts (  1  ). 
The importance of Paneth cell  –  derived antimi-
crobial peptides for antibacterial protection and 
the maintenance of intestinal homeostasis has 
been previously demonstrated (  2, 3  ). Metallo-
proteinase (MMP)-7  –  defi  cient mice, which are 
unable to activate antimicrobial peptides via pro-
teolytic cleavage, show enhanced susceptibility 
to   Salmonella   infection (  2  ). Also, transgenic 
mice expressing human     -defensin 5 in Paneth 
cells show enhanced resistance against bacterial 
challenge (  3  ). Finally, impaired synthesis of an-
timicrobial peptides has recently been shown 
in patients with infl  ammatory bowel disease, 
and a causal link has been proposed (  4  ). 
  Signifi   cant physiological and anatomical 
changes are observed in the gastrointestinal tract 
during the postnatal period. Although neonates 
are fed solely with maternal milk, they soon 
start to ingest additional nutrients and fi  nally 
rely on solid food. These changes induce a sig-
nifi  cant increase and diversifi  cation of the bac-
terial microfl  ora within the intestinal tract (  5  ). 
Also, the spectrum of pathogens that gain en-
trance via the oral route is markedly altered. 
Exposure to important neonate pathogens such 
as   Streptococcus agalactiae   (group B streptococci 
[GBS]),   Escherichia coli   K1, or   Listeria monocyto-
genes   is largely limited to the intense contact 
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  Paneth cell  –  derived enteric antimicrobial peptides provide protection from intestinal infec-
tion and maintenance of enteric homeostasis. Paneth cells, however, evolve only after the 
neonatal period, and the antimicrobial mechanisms that protect the newborn intestine are 
ill defi  ned. Using quantitative reverse transcription  –  polymerase chain reaction, immunohis-
tology, reverse-phase high-performance liquid chromatography, and mass spectrometry, we 
analyzed the antimicrobial repertoire in intestinal epithelial cells during postnatal develop-
ment. Surprisingly, constitutive expression of the cathelin-related antimicrobial peptide 
(CRAMP) was observed, and the processed, antimicrobially active form was identifi  ed in 
neonatal epithelium. Peptide synthesis was limited to the fi  rst two weeks after birth and 
gradually disappeared with the onset of increased stem cell proliferation and epithelial cell 
migration along the crypt  –  villus axis. CRAMP conferred signifi  cant protection from intesti-
nal bacterial growth of the newborn enteric pathogen   Listeria monocytogenes  . Thus, we 
describe the fi  rst example of a complete developmental switch in innate immune effector 
expression and anatomical distribution. Epithelial CRAMP expression might contribute to 
bacterial colonization and the establishment of gut homeostasis, and provide protection 
from enteric infection during the postnatal period. 184 POSTNATAL ANTIMICROBIAL PEPTIDE REPERTOIRE | M  é  nard et al.
    RESULTS   
  Quantitative expression analysis of antimicrobial peptides 
in IECs 
  To investigate gene expression of antimicrobial peptides dur-
ing postnatal intestinal development, we quantitatively exam-
ined messenger RNA (mRNA) levels in highly enriched 
primary IECs prepared according to a recently established pro-
tocol (  10  ). Total RNA of IECs from mouse small intestinal tis-
sue was isolated at the time of birth or at the ages of 6 and 24 h, 
or 3, 6, 14, 21, and 28 d and analyzed by real-time PCR. 
Gene expression was quantifi  ed using a standard curve ob-
tained with a known concentration of the target gene and nor-
malized to the expression level of the housekeeping gene 
  hypoxanthine guanine phosphoribosyl transferase 1   (  Hprt1  ). A grad-
ual up-regulation of C  ryptdin 1   and   5  ,   Angiogenin 4  , and the 
peptide-processing enzyme   Mmp-7   over 2.5  –  3 log during the 
4 wk after birth was observed (  Fig. 1  ).   Detection of   Cryptdin 4   
and the C  ryptdin-related-sequence   (  Crs  )   peptide 1C   expression was 
restricted to IECs isolated from mice at or older than the age of 
14 d. The highest expression levels in adult IECs (day 28) were 
observed for   Crs1C   as well as   Cryptdin 1   and   5  , with expression 
levels reaching   Hprt1   expression. Moderate levels were mea-
sured for   Angiogenin 4   and   Mmp7  , whereas only marginal ex-
pression of   Cryptdin 4   was noted. No   mouse      -defensin     (  Mbd  ) 
with the mother  ’  s intestinal or vaginal microfl  ora during the 
passage through the birth canal (  6  ). These pathogens are 
taken up through the oral route, gain entrance through gas-
trointestinal mucosal membranes, and potentially lead to sys-
temic disease during the postnatal period. 
  In mice, Paneth cells and signifi  cant expression of enteric 
antimicrobial peptides appear only     2 wk after birth accom-
panying the development of intestinal crypts (  7  –  9  ). How-
ever, the innate host defense eff  ector molecules that protect 
the neonate intestine in the absence of Paneth cells and Pan-
eth cell  –  derived antimicrobial peptides are ill defi  ned. In this 
paper, we describe a systematic analysis of the expression of 
antimicrobial peptides by intestinal epithelial cells (IECs) 
during the postnatal period. We confi  rm absent or marginal 
synthesis of known enteric antimicrobial peptides during the 
postnatal period. Strikingly, we demonstrate strong expres-
sion of the cathelicidin cathelin-related antimicrobial peptide 
(CRAMP) in IECs and restriction of CRAMP production to 
the neonatal period. Thus, this study for the fi  rst time de-
scribes a complete developmental switch in the expression of 
antimicrobial peptides and their anatomical distribution. Our 
fi  ndings highlight the variability of the innate immune de-
fense mechanisms to combat the changing microbial chal-
lenge encountered by the developing organism. 
    Figure 1.         Postnatal expression of antimicrobial peptides in IECs.   Quantitative mRNA expression analysis for the indicated antimicrobial peptides 
and the peptide-processing enzyme MMP7 in primary IECs isolated from the small intestinal tissue of fetal, 6- and 24-h-, and 3-, 6-, 14-, 21-, and 28-
d-old mice. Occludin and Zo-1 are involved in the formation of epithelial tight junction and were included as controls. Values represent the mean   ±   SD of 
gene expression determined in total IECs from three individual mice and indicate the target/housekeeping (  Hprt1  ) gene expression ratio.     JEM VOL. 205, January 21, 2008 
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crobial activity against   Bacillus megaterium   (strain Bm11) using 
a standardized agar diff   usion assay (  11  ). In addition, mass 
spectrometry was performed on positive fractions to identify 
antimicrobially active substances. The presence of a large va-
riety of cryptdins and CRS peptide homo- and heterodimers 
was confi  rmed by mass spectrometric analysis in fractions 
45  –  55 from adult IECs (day 28) associated with signifi  cant anti-
bacterial activity, as recently reported (  Fig. 2 A  ) (  11, 12  ).   
  In contrast, the corresponding fractions obtained from 
neonate IECs completely lacked antimicrobial activity and 
were devoid of known enteric antimicrobial peptides (  Fig. 
2 B  ). Antimicrobial activity in fractions 65  –  95 was associated 
with the presence of ribosomal proteins, known cationic 
molecules with antibacterial activity expected to be found in 
both neonate and adult tissue. Additional antimicrobial activ-
ity eluting in fractions 80  –  82 from day 28 mice correlated 
with the elution position of a Paneth cell  –  derived lysozyme. 
To confi  rm these fi  ndings, intestinal tissue of newborn and 
6  –  28-d-old mice was stained for cryptdin 2, a prominent 
member of the family of Paneth cell  –  derived peptides expressed 
expression (including   Mbd 1  ,   2  ,   4  , and   14  ) was detected at any 
time point in primary IECs (not depicted). As controls, genes 
encoding   Occludin  ,   Zonula occludens protein 1   (  Zo-1  ), and   E-cad-
herin  , all involved in the formation of epithelial tight junctions, 
as well as   Angiogenin 1  , which has not been associated with an-
timicrobial function, were included in the analysis. No signifi  -
cant changes in the expression level of these genes over the 
observed time period were noted (  Angiogenin 1   and   E-cadherin   
[not depicted]). Thus, signifi  cant alterations of intestinal epi-
thelial antimicrobial peptide expression were detected with a 
marked up-regulation from day 14 and onwards. 
  Analysis of antibacterial activity and immunodetection 
of antimicrobial peptides in the developing intestine 
  To verify the developmental changes of intestinal antimicro-
bial peptide expression, detection at the protein level and 
quantifi  cation of antibacterial activity were performed. IECs 
isolated from newborn (day 1) or adult (day 28) small intesti-
nal tissue were homogenized, extracted, and fractionated by 
reverse-phase HPLC. All fractions were analyzed for antimi-
    Figure 2.         Comparison of antibacterial activity and antimicrobial peptide expression between neonate and adult IECs.   Cationic  antimicrobial 
peptides from 28-d-old adult (A) and 1-d-old neonate (B) mice were extracted from isolated IECs and fractionated by reverse-phase HPLC. (top) Compo-
nents eluting between 10 and 50% acetonitrile (ACN). Absorbance was measured at      = 214 nm (A  214  ). (bottom) Fractions were tested for antibacterial 
activity using   B. megaterium   Bm11 as the indicator strain in an agar diffusion assay. The killing zone diameter is indicated the fi  gure. (C) Immunostaining 
for cryptdin 2 (red, top) and the Paneth cell marker lysozyme (red, bottom) in the small intestinal tissue of 1-, 6-, 14-, 21-, and 28-d-old mice. MFP488 
phalloidin (green) and DAPI (blue) were used as counterstaining. Arrows indicate the cryptdin 2  –   and lysozyme-positive Paneth cells at the bottom of the 
intestinal crypts. Bar, 75   μ  m.     186 POSTNATAL ANTIMICROBIAL PEPTIDE REPERTOIRE | M  é  nard et al.
histology (  Fig. 4, B and C  ).   Evaluation of m-IC  cl2   cells cul-
tured under diff  erentiating and polarizing conditions revealed 
a signifi  cant and inducible antibacterial activity in cell lysate 
and culture supernatant (  Fig. 4, D and E  ). In addition, m-IC  cl2   
cells express pancreatic elastase and proteinase 3 (not depicted) 
and, thus, confi  rm the phenotype observed in primary neo-
nate IECs isolated from newborn mice. 
  Loss of intestinal epithelial CRAMP expression 
is accompanied by increased proliferation 
  Cathelicidins have been reported to promote cell diff  erentia-
tion and angiogenesis, and enhance cell proliferation and mi-
gration ( 15, 16 ). Neonatal CRAMP expression might thereby 
contribute to postnatal organ development and intestinal cell 
diff  erentiation. Therefore, the postnatal development of the 
intestinal mucosa and the appearance of intestinal Paneth cells 
were examined during the postnatal period of Cramp  +/+   and 
Cramp      /      mice. However, Paneth cells and Paneth cell  –  derived 
eff  ector molecules were similarly detected in Cramp  +/+   and 
Cramp      /      mice at 14 d after birth (  Fig. 5, A and B  ).   Also, re-
combinant CRAMP had no signifi  cant eff  ect on intestinal epi-
thelial proliferation or cell viability (Fig. S1, B and C). Although 
CRAMP signifi  cantly inhibited LPS-mediated stimulation 
of naive epithelial cells similar to other antimicrobial peptides, 
it showed no eff  ect on endotoxin-tolerant epithelial cells 
(Fig. S1, D and E) (  12, 17  ). 
  Mucosal colonization of the intestinal tract starts immedi-
ately after birth, leading to an increasingly dense and complex 
microbial fl  ora during the fi  rst weeks of life (  5  ). To examine 
a possible eff  ect of microbial colonization on the disappearance 
of CRAMP expression, conventionally bred and germ-free  –
  bred animals were compared. However, epithelial CRAMP 
expression was restricted to the neonatal period irrespective 
of colonization by the microbial fl  ora (  Fig. 5 C  ). 
  Strikingly, careful analysis of epithelial CRAMP expres-
sion during the third week after birth suggested that disap-
pearance of CRAMP after the postnatal period was not 
caused by down-regulation of transcriptional activity but 
rather occurred in an anatomically compartmentalized fash-
ion. Reduced expression was fi  rst noticed at the level of the 
crypts and lower villi and reached the tip of the villi some 
days later (  Fig. 5 D  ). Loss of CRAMP expression was accom-
panied by an increase of epithelial cell proliferation and the 
formation of intestinal crypts (  Fig. 5 E and Fig. 2C  ). These 
data are in accordance with a recent report on low Wnt sig-
naling activity in the intervillus region directly after birth and 
increased activity in the crypt area of adult individuals (  18  ). 
They further suggest that CRAMP expression is limited to 
the neonate epithelium and lost during the developmental 
changes that occur in the postnatal period associated with in-
creased IEC proliferation and diff  erentiation. 
  CRAMP-mediated antibacterial activity against commensal 
and pathogenic enteric bacteria 
  To establish a possible role in enteric host protection, we next 
tested the CRAMP-mediated antibacterial activity against 
in mouse small intestinal tissue (  Fig. 2 C  ). Again, cryptdin 2 
expression was completely absent in neonate (1- and 6-d-old) 
mice, but increasing staining was found in 14- and 21-d-old 
mice, reaching maximum expression only in adult (day 28) 
animals. The clear restriction of cryptdin 2 to intestinal crypt 
Paneth cells prompted us to include staining for the Paneth 
cell marker lysozyme (  Fig. 2 C  ). Indeed, lysozyme staining 
revealed a very similar picture confi  rming a close association 
of postnatal Paneth cell diff  erentiation with enteric antimi-
crobial peptide expression. These data suggest that the estab-
lished enteric antimicrobial peptides are absent in neonatal 
intestinal epithelium. 
  Detection of the cathelicidin CRAMP in neonate 
intestinal tissue 
  To identify protective antibacterial molecules in mouse neo-
nate intestine, gene expression analysis for the mouse   Cramp   
was included. Strikingly, signifi  cant expression of   Cramp   in 
primary IECs was found during the early postnatal develop-
mental stages but completely disappeared between days 14 
and 21, concomitant with the appearance of Paneth cell  –
    derived peptides (  Fig. 3 A  ).   Similar results were obtained 
  using a commercial hybridization probe  –  based assay for quan-
titative determination of   Cramp   mRNA (not depicted). Also, 
primary IECs isolated from older healthy individuals did not 
reveal any detectable constitutive   Cramp   expression (Fig. 
S1A, available at http://www.jem.org/cgi/content/full/jem
.20071022/DC1). Immunoblotting of neonate (day 3) and 
adult (day 28) IECs confi  rmed the restriction of CRAMP 
expression to newborn epithelium and revealed the presence 
of the processed mature form of CRAMP in neonate IECs 
(  Fig. 3 B  , left). Although the cathelin propeptide was exclu-
sively found in cell lysate, the processed mature form was 
additionally seen in cell supernatant, suggesting intracellular 
cleavage before secretion of the biologically active peptide by 
IECs (  Fig. 3 B  , right). Restriction of CRAMP expression to 
the neonate period was also noted by immunostaining of in-
testinal tissue of 3-, 6-, 14-, 21-, and 28-d-old mice (  Fig. 3 C  ). 
Enzymatic processing could be performed by pancreatic elas-
tase or proteinase 3, both of which are expressed in primary 
neonatal intestinal epithelium (  Fig. 3 D  ). Alternatively, tryp-
sin activity has recently been identifi  ed in mouse small intes-
tinal tissue (  13  ). Thus, constitutive expression and production 
of the processed mature form of CRAMP was detected in 
small intestinal epithelium restricted to the neonatal period. 
  m-IC  cl2   cells derived from E20 fetal tissue express CRAMP 
  Bens et al. have recently described a highly diff  erentiated and 
polarized IEC line derived from embryonic day 20 fetuses of 
transgenic mice carrying the large T antigen of the simian 
  virus 40 under the control of the 5     regulatory sequence from 
the     L  -  pyruvate kinase gene (  14  ). Although none of the estab-
lished enteric antimicrobial peptides, such as     -defensins, 
CRS peptides, or angiogenin 4, were detectable by RT-PCR 
(  Fig. 4 A  ) or mass spectrometry (not depicted), the synthesis 
of CRAMP was confi  rmed by FACS analysis and immuno-JEM VOL. 205, January 21, 2008 
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sulting in a 3  –  4 log decrease of viable bacteria after 2 h was 
noted against selected Gram-positive and -negative intestinal 
commensal bacteria of the small intestine such as   S. gallinaceus  ,   
gut commensal bacteria, as well as defi  ned pathogenic bacteria 
known to be transmitted to the neonate organism during pas-
sage through the birth canal (  6  ). Rapid bacterial killing re-
    Figure 3.         CRAMP expression in IECs during postnatal development.   (A) Quantitative analysis of CRAMP mRNA expression in primary IECs isolated 
from the small intestinal tissue of fetal, 6- and 24-h-, and 3-, 6-, 14-, 21-, and 28-d-old mice. Values represent the mean   ±   SD of gene expression deter-
mined in total IECs from three individual mice and indicate the target/housekeeping (  Hprt1  ) gene expression ratio. n.d., not detectable. (B) Immunoblot for 
CRAMP in cell lysate of isolated IECs from 3- and 28-d-old mice (left) as well as in culture supernatant and cell pellet of isolated IECs from 3-d-old mice 
(right). Actin staining was included to demonstrate equal protein loading. (C) Immunostaining for CRAMP (red) in the small intestinal tissue of 3-, 6-, 14-, 
21-, and 28-d-old mice. The FITC-conjugated lectin wheat germ agglutinin (WGA; green) binding to the mucus surface, and DAPI (blue) was used to delin-
eate the anatomical structures of the mucoid surface and cell nuclei, respectively. Bar, 75   μ  m. (D) RT-PCR expression analysis for the known CRAMP-
cleaving enzymes proteinase 3, pancreatic elastase, and kallikrein 5 and 7 in primary IECs of 1-, 6-, 14-, and 28-d-old mice, as well total small intestinal 
(SI) and skin tissue as positive control. H  2  O and genomic DNA were included as negative controls for the intron-spanning primers.     188 POSTNATAL ANTIMICROBIAL PEPTIDE REPERTOIRE | M  é  nard et al.
infl  ammatory reaction (  19, 20  ). This allows applica  tion of 
signifi  cant bacterial numbers, minimizes the possible eff  ect 
of infi  ltrating granulocytes, and, thus, favors the analysis of 
the intraluminal intestinal host defense. 5-d-old wild-type 
(  Cramp  +/+    ) and   Cramp  -defi  cient  (  Cramp       /        ) neonate mice 
were orally challenged with 10  6   CFU of   L. monocytogenes  . In-
deed, the number of viable   L. monocytogenes   in intestinal tis-
sue 24 h after oral infection of  Cramp  +/+     mice was signifi  cantly 
diminished (  >  2 log). In contrast, no decrease of viable bacte-
ria was noted in   Cramp       /         mice, resulting in a signifi  cant dif-
ference between both groups of animals (P   <   0.05;   Fig. 6 C  ). 
Analysis of spleen and liver tissue 24 h after oral infection 
confi  rmed the low invasion rate with viable   L. monocytogenes   
in none of the   Cramp  +/+     mice and only 2 out of 11   Cramp       /         
mice (not depicted). Notably, these results illustrate that the 
experimental setting mainly refl  ects the intraluminal host de-
fense. Thus, intestinal CRAMP harbors signifi  cant antibacte-
rial activity against commensal and pathogenic microorganisms 
Lactobacillus murinus  ,   L. reuteri  , and the nonpathogenic   E. coli   
strain D21 at peptide concentrations between 10 and 50   μ  g/ml 
(  Fig. 6 A  ).   Similarly, perinatally transmitted pathogens asso-
ciated with systemic disease in neonates such as   S. agalactiae   
(GBS), capsule-positive   E. coli   K1, or   Salmonella enterica   se-
rovar Typhimurium (  S.   Typhimurium) were susceptible 
toward the bacterial killing activity of CRAMP (  Fig. 6 B  ).
  L. monocytogenes,   a major cause of neonatal meningitis after 
oral ingestion during birth (described as late onset disease in con-
trast to the early onset disease after transplacental transmission) 
demonstrated particular susceptibility, with 99% killing within 
2 h by   <  1   μ  g/ml CRAMP (  Fig. 6 B  ). 
  Finally, a neonate oral infection model with   L. monocyto-
genes   was chosen to verify the protective activity of intestinal 
epithelial CRAMP expression in vivo. Because of structural 
diff  erences of the epithelial receptor E-cadherin between mice 
and men, the invasion rate of   L. monocytogenes   after oral infec-
tion of mice is very low and results in only a marginal local 
    Figure 4.         Intestinal epithelial m-IC  c12   cells derived from embryonic day 20 mouse fetuses exhibit antimicrobial activity and express 
CRAMP.   (A) Absence of enteric antimicrobial peptide expression in fetus-derived m-IC  cl2   cells measured by RT-PCR. SI, total small intestine. 
(B) FACS analysis and (C) immunostaining of CRAMP expression by m-IC  cl2   cells. Normal rabbit polyclonal serum was used as control. Bar, 10   μ  m. 
(D) Agar diffusion assay demonstrating antibacterial activity against the indicator strain   B. megaterium   Bm11 in cell lysate and supernatant of 
unstimulated and IL-1      –   and LPS-stimulated (25 and 100 ng/ml, respectively) m-IC  cl2   cells. (E) Time course of antibacterial activity in m-IC  cl2  
cell supernatant after stimulation with 100 ng/ml LPS. Activity is given as cecropin units, with one unit corresponding to the activity of 1 ng 
of cecropin.     JEM VOL. 205, January 21, 2008 
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has been well established, less is known about the antimicro-
bial protection and particular susceptibility toward bacterial 
infections during the neonatal period. Importantly, low ex-
pression of Paneth cell  –  derived antimicrobial peptides has 
also been noted in human neonates (  21  ). Besides infection via 
the transplacental route during pregnancy, several microbial 
organisms are transmitted from the mother to the newborn 
during passage through the birth canal, gain entrance via the 
intestinal tract, and may evoke systemic disease in neonates. 
Examples are GBS (  S. agalactiae  ),   E. coli   K1,   S.   Typhimurium, 
and might contribute to protect the intestinal mucosa against 
pathogenic bacteria and restrict growth or shape the compo-
sition of the commensal microfl  ora. 
    DISCUSSION   
  The present work demonstrates an unexpected and unprece-
dented complete change in the small intestinal antimicrobial 
peptide repertoire and anatomical distribution from the post-
natal period to weaning. Although the important role of Pan-
eth cell  –  derived antimicrobial peptides in adult individuals 
    Figure 5.         Loss of CRAMP expression is associated with enhanced epithelial cell proliferation during postnatal development.   Immunostaining 
for (A) lysozyme and (B) cryptdin 2 (red) in small intestinal tissue of 6-, 14-, and 21-d-old Cramp  +/+   and  Cramp    /     mice to demonstrate similar organ 
development. Bars, 25   μ  m. (C) Immunostaining for CRAMP (red) in the small intestinal tissue of 6-d-old as well as adult conventionally bred (left) and 
germ-free  –  bred (right) mice. Bar, 75   μ  m. (D) Immunostaining for CRAMP (red) in small intestinal tissue of 14-, 16-, and 18-d-old mice. Bar, 75   μ  m. 
(E) Immunostaining for the cell division marker Ki67 (red) in the small intestinal tissue of 1-, 6-, 14-, 21-, and 28-d-old mice illustrating the signifi  cant 
enhancement of epithelial proliferation in the intestinal crypts during the third week of life. MFP488 phalloidin (green) and DAPI (blue) were used as counter-
staining.  Bar,  75   μ m.   190 POSTNATAL ANTIMICROBIAL PEPTIDE REPERTOIRE | M  é  nard et al.
documented developmental change in the enteric antibacterial 
peptide repertoire might refl  ect the age-related spectrum of 
orally ingested pathogens. Similarly, CRAMP expression has 
been detected in vernix caseosa and neonate skin (  22  –  24  ). 
Together with our results, these data suggest that CRAMP 
plays a prominent role in the protection of the newborn. 
  Cathelicidins are released by proteolytic cleavage from 
their precursor molecules. Expression of the precursor pep-
tide has been noted in myeloid cells, keratinocytes, and epi-
thelial cells from the skin, lung, stomach, colon, meninges, and 
eye, as well as endothelial cells (  25  –  28  ). Although they represent 
a large and important group of antimicrobial peptides in a 
variety of mammals, only one member, LL-37 and CRAMP, 
is encoded in humans and mice, respectively. Signifi  cant 
cathelicidin expression has previously been noted in the gas-
trointestinal tract, such as human gastric or colonic tissue, 
with higher expression levels in individuals with persistent 
bacterial infection or chronic infl  ammation (  27, 29  ). Although 
our results obtained using highly purifi  ed primary IECs indi-
cated the absence of constitutive   Cramp   expression in adult 
individuals,   Cramp   mRNA was recently noted in total adult 
small intestinal tissue (  30  ). The diff  erent results might refl  ect 
expression by resident tissue myeloid cells. However, we 
cannot rule out the reappearance of small intestinal epithelial 
  Cramp   expression in adult individuals during conditions such 
as tumorigenesis or infl  ammatory processes. 
  Importantly, lack of cathelicidin synthesis was associated 
with clinical disease, such as periodontitis, in human individ-
uals with congenital neutropenia (Kostmann syndrome) and 
enhanced susceptibility to recurrent urinary tract infection 
(  26, 31  ). CRAMP expression also conferred protection from 
invasive skin infection by group A streptococci and   Citrobacter 
rodentium    –  induced colitis in mice (  25, 32  ). The clinical 
importance of CRAMP was further underlined by the de-
scription of mechanisms to gain resistance against peptide-
mediated killing by several human pathogenic bacteria (  33, 34  ). 
In addition to the broad and potent antibacterial activity, 
cathelicidin-derived antimicrobial peptides have also been 
noted to exert other biological activities so as to promote cell 
diff  erentiation and to stimulate angiogenesis and epithelial 
cell proliferation (  15, 16  ). Although our results do not support 
an involvement of epithelial CRAMP in the postnatal intes-
tinal organ development, other CRAMP-mediated biological 
eff  ects on neonate gut homeostasis cannot be excluded. 
  The fi  nding that germ-free mice, similar to convention-
ally bred mice, completely lost intestinal epithelial CRAMP 
expression precludes an active role of the enteric microfl  ora 
in the down-regulation of intestinal CRAMP expression. Sim-
ilar results have been found for cryptdin expression in Paneth 
cells (  11  ). The close temporal association between the loss of 
CRAMP expression and developmental changes such as the 
increase of epithelial proliferation, the emergence of crypts, 
and the appearance of mature Paneth cells instead indicate a 
developmentally controlled process. Indeed, cathelicidin ex-
pression has previously been linked to cell diff  erentiation 
and exposure to diff  erentiation-promoting agents (  35, 36  ). 
  Ureaplasma urealyticum  , or   L. monocytogenes  , which all colonize 
the urogenital or lower intestinal tract of the mother and cause 
signifi  cant morbidity in newborns during the postnatal period. 
Thus, expression of CRAMP in neonate intestine and the 
    Figure 6.         CRAMP rapidly kills commensal and pathogenic bacteria 
and controls the growth of   L. monocytogenes   in neonate small 
intestine in vivo.   Antibacterial activity of recombinant CRAMP against 
Gram-positive and -negative (A) commensal bacteria such as   L. murinus , 
  L. reuteri ,   S. gallinaceus  , and   E. coli D21  , and (B) pathogenic bacteria such 
as   L. monocytogenes ,   S.   Typhimurium,   S. agalactiae  , and capsule-positive 
  E. coli   K1. Viable bacteria were determined after 2 h in the presence of the 
indicated peptide concentration. (C) 5-d-old Cramp  +/+   (squares)  and 
CRAMP     /     (triangles) newborn mice were orally infected with 10  6    
L. monocytogenes   in a volume of 5   μ  l, and the number of viable bacteria 
in small intestinal tissue was counted 24 h after infection. Squares and 
triangles indicate the bacterial load in each individual animal. Horizontal 
bars indicate the median   ±   interquartile range.     JEM VOL. 205, January 21, 2008 
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GGTGCT-3    ; reverse, 5    -TTGTGGCTGCGCTTGTGGTGAGTAA-3    ). 
The primers for C  ryptin 1   (forward [Defcrp  130  ], 5    -AAGAGACTAAAA  C  T  -
GA  GGAGCAGC-3    ; reverse, 5    -CGCAGCAGAGCGTGTA-3    ),   Cryptin 4 
(forward [Defcrp  130  ], 5    -AAGAGACTAAAACTGAGGAGCAGC-3    ; 
reverse, 5    -CGGCGGGGGCAGCAGTA-3    ), and   Cryptin 5   (forward [De-
fcrp  130  ], 5    -AAGAGACTAAAACTGAGGAGCAGC-3    ; reverse, 5    -GC  A-
GCAGAATACGAAAGT-3    ) were as previously described (  9  ).   Hprt1   
(forward, 5   -TGATCAGTCAACGGGGGACA-3    ; reverse, 5   -TTCGAG-
AGGTCCTTTTCACCA-3    ) and          2  -microglobulin   (  b2M  ; forward, 
5    -T  G  G  T  GC  TTGTCTCACTGAML-3    ; reverse, 5    -C  C  G  T  T  C  T  T  C  A  G-
CA  TTTGGAT-3    ) were used as endogenous controls to normalize gene 
expression levels. Normalization to both   Hprt1   and   b2M   revealed very simi-
lar results; the data shown in the fi  gures were obtained after normalization 
to   Hprt1  . All primers used in this study  —  except for   Angiogenin 1   and   4  , as 
well as   Mbd 1  ,   2  ,   4  , and   14    —  were intron spanning, as demonstrated by the 
absence of amplifi  cation from genomic DNA. Non  –  intron-spanning PCR 
amplifi  cation was preceded by an RQ1 RNase-free DNase (Promega) digestion 
step, including the appropriate controls. SYBR green  –  based real-time PCRs 
for cDNA quantifi  cation were performed in 20-  μ  l volumes by using both 
standard curves and the comparative C  T   method on a LightCycler instrument 
(Roche) and a sequence detector (ABI Prism 7900; Applied Biosystems). 
  Additionally, the comparative C  T   method was used to confi  rm altera-
tions in   Cramp   gene expression by using Quantitect assays QT01195922 
(  Cramp  ) and QT00166768 (  Hprt1  ; both from QIAGEN) and, additionally, 
by using TaqMan gene expression assays Mm00438285_m1 (  Cramp  ) and 
Mm00446968_m1 (  Hprt1  ; both from Applied Biosystems), according to the 
manufacturers  ’   instructions. Quantitect assays were run on the LightCycler 
instrument, and Taqman assays were performed with the ABI Prism 7900 
sequence detector. Quantitative analysis was performed according to the 
manufacturer  ’  s manuals and tutorials (available at http://www.appliedbio-
systems.com). All PCRs were run in triplicate. 
  HPLC fractionation and mass spectrometric analysis.     Cationic anti-
microbial peptides were extracted from isolated IECs of newborn and adult 
C57BL/6 mice or m-IC  cl2   cell lysate, according to a published protocol (  12  ). 
The antibacterial activity of HPLC fractions was analyzed using a zone inhi-
bition assay using   B. megaterium   strain 11 (  11  ). Cell-culture supernatant was 
purifi  ed using Sep-Pak Light tC18 cartridges (Waters Corp.) before antibac-
terial testing and mass spectrometric analysis. Matrix-assisted laser desorp-
tion-ionization time-of-fl   ight mass spectrometry analysis was performed 
with a Refl  ex III instrument (Bruker Daltronics), as recently described (  11  ). 
  Immunohistology, fl  ow cytometry, and immunoblotting.     Immuno-
staining was performed on small intestines from newborn and 1-, 3-, 6-, 14-, 
16-, 18-, 21-, and 28-d-old mice. Paraformaldehyde-fi  xed slides were depa-
raffi   nized and heated at 120  °  C for 3 min in 10 mM Na-citrate, pH 6, to 
improve antigen accessibility. Rabbit antilysozyme antiserum (1:250; Dako), 
anti  –  cryptdin 2 (1:1,000), or anti-Ki67 protein antiserum (1:2,000; provided 
by T. Scholzen, Research Center Borstel, Borstel, Germany) was incubated 
for 1 h at room temperature and detected using a Texas red  –  conjugated 
anti  –  rabbit secondary antibody (1:50; Jackson ImmunoResearch Laboratories). 
Cryosections were acetone fi  xed and incubated with rabbit anti-CRAMP 
antiserum at a fi  nal dilution of 1:500 for 90 min at room temperature. Primary 
antibody detection was performed with a goat anti  –  rabbit Cy3-conjugated 
secondary antibody (Jackson ImmunoResearch Laboratories). Counterstain-
ing was performed with MFP488 phalloidin (MoBiTec) or fl  uorescein-con-
jugated wheat germ agglutinin at a dilution of 1:50 (Vector Laboratories), as 
indicated in the fi  gures. Slides were mounted in DAPI containing Vecta-
shield (Vector Laboratories) and visualized using an ApoTome-equipped 
microscope (Axioplan 2) connected to a digital camera (AxioCam M  r  ; all 
purchased from Carl Zeiss, Inc.). CRAMP expression was visualized by fl  ow 
cytometry after fi  xation (Cytofi  x; BD Biosciences), with permeabilization in 
Ca  2+  - and Mg  2+  -free PBS containing 0.5% saponin and 2% FCS using a rab-
bit anti-CRAMP antiserum (1:500) or control serum in combination with a 
TR-conjugated anti  –  rabbit secondary antibody. Cells were analyzed on a 
FACSCalibur apparatus (BD Biosciences). Immunoblotting was performed 
  Developmental regulation is also supported by the recently 
identifi  ed diff  erential expression profi  le of the Wnt transcriptional 
eff  ectors Tcf3 and Tcf4 during the development of the mouse 
intestinal epithelium (  18  ). The identifi  ed increase in epithelial 
proliferation during the postnatal development is paralleled by 
enhanced Wnt signaling in the area of cellular proliferation (  18  ). 
The restriction of CRAMP expression to neonate epithelium 
and the gradual loss of CRAMP-positive cells along the 
crypt  –  villus axis might therefore result from a combined de-
velopmental program of cell diff  erentiation and proliferation. 
  In conclusion, we describe a complete change of the an-
timicrobial peptide repertoire in the intestinal epithelium 
during the postnatal period. This switch of the antimicrobial 
peptide expression highlights the variability of the innate host 
defense system to encounter the changing spectrum of mi-
crobial challenge. Neonate enteric CRAMP expression might 
provide protection from pathogens and contribute to the 
establishment of a stable host  –  microbe homeostasis. The es-
tablishment of the physiological microfl  ora in combination with 
an increase in epithelial cell turnover in adult individuals might 
later facilitate restriction of antimicrobial peptide production to 
Paneth cells at the bottom of intestinal crypts to form a more 
dynamic barrier that is effi   cient against bacterial pathogens but 
allows the existence of a bacterial microfl  ora. 
  MATERIALS AND METHODS 
  Isolation of primary IECs.     C57BL/6 mice were purchased from Charles 
River Laboratories, housed under specifi  c pathogen-free conditions, and 
treated in accordance with the local animal protection legislation (Regier-
ungspr  ä  sidium Stuttgart). Germ-free  –   as well as conventionally bred mice 
were obtained from the Gnotobiotic Facility (Karolinska Institutet). Mice 
were killed by cervical dislocation, and the small intestine was removed. Pri-
mary IECs were isolated from the intestinal tissue at diff  erent ages based on 
a published protocol (  10  ). All tissue, except that from 0 h mice, was obtained 
from spontaneously delivered newborns. 0-h-old IECs were isolated from 
mice born by caesarean section after natural birth of the fi  rst sibling to ensure 
maturity of the obtained neonate tissue. 
  Quantitative real-time PCR analysis.     Total RNA was obtained using 
TRI  zol   reagent (Invitrogen) according to the manufacturer ’  s protocol. Com-
plementary DNA (cDNA) was synthesized from 1   μ  g of total mRNA using 
oligo(dT)  18   primer from the fi  rst-strand cDNA synthesis AMV kit (Roche). 
The following primers were used for cDNA amplifi  cation:   Angiogenin 1   
(forward, 5    -AGGCCCGTTGTTCTTGATCT-3    ; reverse, 5    -T  G  A  G  GT-
T  AGGCTTCTTCTCTTCA-3    ),   Angiogenin 4   (forward, 5    -G  A  C  A  A  T    G  A-
G  C  CCATGTCCTT-3    ; reverse, 5   -TTTGGCTTGGCATCATAGTG-3    ), 
  Cramp   (forward, 5    -CCGAGCTGTGGATGACTTCAAML-3    ; reverse,
5    -C  T  G  C  C  C  CCATACACTGCTTCAC-3    ),   Crs1-C   (forward, 5    -G  T  C-
TCCTTTGGAGGCACAGA-3    ; reverse, 5    -GCTTGGGTGGTGATAGC-
A  GT-3    ),   E-cadherin   (forward, 5    -GGCTTCAGTTCCGAGGTCTA-3    ;
re  verse, 5    -CGAAAAGAAGGCTGTCCTTG-3    ),   Elastase   (forward, 
5    -  T  G  T  GGAC  AC  AG  T          A  CCGAGGA   -3    ; reverse, 5    -  GGTCATC  A  C-
C  C  AGTTGCTTC  -3    ),   Kallikrein 5   (forward, 5    -  CAATGGCTACCCTG  A-
TCACA  -3    ; reverse, 5   -  GTCCTCCCCAGACTTGGAAT  -3    ),  Kallikrein 7 
(forward, 5    -  CAGGGAGTGCAAGAAGGTGT  -3    ; reverse, 5    -  T  A  G  G  T  A-
C  C  C  C  A  GGACACCAG  -3    ),   Mmp-7   (forward, 5    -TTTGAT  G  G  G  C  C  A  G  G-
GA  ACACTCTA-3    ; reverse, 5   -ATGGGTGGCAGCAAACAGGAAGT-3    ),
  Occludin   (forward, 5    -AGCGCTATCCTGGGCATCAT-3    ; reverse, 
5    -A  T  C  C  ATCTTTCTTCGGGTTTTCAC-3    ),   Proteinase 3   (forward, 
5    -  A  C  G  GTGG  TCACCTTCCTATG  -3    ; reverse, 5    -  GCGAAGAAATC-
AGGGAACTG  -3    ), and   Zo-1   (forward, 5    -TCTGAGGGGAAGGCGGAT-192 POSTNATAL ANTIMICROBIAL PEPTIDE REPERTOIRE | M  é  nard et al.
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as recently described (  10  ). Membranes were incubated overnight at 4  °  C, 
with the primary antibody provided by B. Agarberth (Karolinska Institute, 
Stockholm, Sweden) at a 1:1,000 dilution. Detection was performed using 
peroxidase-conjugated goat anti  –  rabbit secondary antibody (Jackson Immuno-
Research Laboratories) in combination with the ECL kit (GE Healthcare). 
To confi  rm equal loading, actin staining was used with a rabbit polyclonal 
actin antiserum (Sigma-Aldrich). 
  Determination of CRAMP antibacterial activity and bacterial 
challenge.     Mature CRAMP peptide ISRLAGLLRKGGEKIGEKLKKIG  QK-
IKNFFQKLVPQPE was synthesized with a purity of   >  95% (Innovagen) 
and tested by HPLC and mass spectrometry.   L. murinus  ,   L. reuteri  ,   and S. gal-
linaceus   were mouse small intestinal isolates identifi   ed biochemically and 
confi  rmed by 16S ribosomal RNA gene sequencing.   S.   Typhimurium 14028 
was received from the American Type Culture Collection, and the non-
pathogenic   E. coli   strain D21 and the clinical isolate   L. monocytogenes   type 1 
were received from the laboratory strain collection. Encapsulated   E. coli   K1 
and   S. agalactiae   (GBS) were human clinical isolates provided by R. Berner 
(University of Freiburg, Freiburg, Germany). The antibacterial activity of 
peptides was evaluated with a broth microdilution assay in 10 mM sodium 
phosphate buff  er supplemented with 1% tryptic soy broth supplemented 
with 0.5% yeast extract (TSB-Y; Difco) for   L. monocytogenes  ,   E. coli   K1,   
S. gallinaceus  , and S.   agalactiae  . Sodium phosphate buff  er was supplemented with 
1% MRS broth for lactobacilli species and with 1% Luria-Bertani broth for 
  E. coli   D21 and   S.   Typhimurium, as previously described (  37  ). 10  4   bacteria 
grown to mid-logarithmic phase were coincubated in 100   μ  l with or with-
out the addition of peptide at the concentrations indicated in the fi  gures (0.5, 
1, 5, 10, 20, and 50   μ  g/ml). The number of viable bacteria (CFU) was ana-
lyzed after 2 h by serial dilution.   Cramp  -defi  cient (  Cramp       /        ) as well as 
  Cramp  +/+     129/SvJ mice were bred at the Animal Facility of the Microbiol-
ogy and Tumor Biology Center (Karolinska Institutet). For in vivo analysis, 
5-d-old   Cramp  +/+     and   Cramp       /         mice were orally infected with 10  6   CFU 
  L. monocytogenes   in 5   μ  l of bicarbonate buff  er. 24 h after infection, mice were 
killed and the small intestine was removed and homogenized. The number 
of viable bacteria per gram of tissue was determined by serial dilution. All in 
vivo experiments were conducted in agreement with European Communities 
Council Directive 86/609/EEC and Swedish animal protection legislation. 
  Statistical analysis.     Results are given as the mean   ±   SD or median   ±   inter-
quartile range, as indicated. Statistical analyses were performed using the 
Student  ’  s   t   test. P   <   0.05 was considered signifi  cant. 
  Online supplemental material.     Fig. S1 A shows no detectable   Cramp   
expression in primary IECs isolated from small intestinal tissue of 8- and 
15-wk-old mice using quantitative mRNA analysis. The absence of an eff  ect 
of CRAMP on epithelial cell proliferation and cell viability is demonstrated 
in Fig. S1 (B and C). Fig. S1 (D and E) illustrate the strong endotoxin-block-
ing activity of CRAMP on naive cells but the absence of a detectable eff  ect 
of CRAMP on LPS-tolerized IECs. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20071022/DC1. 
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